Mirko Theis

2.1k total citations
26 papers, 937 citations indexed

About

Mirko Theis is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mirko Theis has authored 26 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Mirko Theis's work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (9 papers) and CRISPR and Genetic Engineering (8 papers). Mirko Theis is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (9 papers) and CRISPR and Genetic Engineering (8 papers). Mirko Theis collaborates with scholars based in Germany, United States and Switzerland. Mirko Theis's co-authors include Frank Buchholz, Ralf Kittler, Mikołaj Słabicki, Ina Poser, Anthony A. Hyman, Maciej Paszkowski‐Rogacz, Vineeth Surendranath, Michael Famulok, Anne‐Kristin Heninger and Bianca Habermann and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Mirko Theis

26 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirko Theis Germany 15 807 239 162 78 64 26 937
Markus Decker Germany 9 551 0.7× 278 1.2× 133 0.8× 274 3.5× 39 0.6× 13 826
Yehuda Brody Israel 13 1.4k 1.7× 92 0.4× 133 0.8× 65 0.8× 116 1.8× 23 1.5k
Veronique Jonckheere Belgium 17 641 0.8× 259 1.1× 73 0.5× 199 2.6× 70 1.1× 31 899
Sabrina Fritah Luxembourg 11 742 0.9× 94 0.4× 277 1.7× 149 1.9× 51 0.8× 17 947
Charalampos Lazaris United States 11 782 1.0× 98 0.4× 76 0.5× 88 1.1× 63 1.0× 14 947
Stefanie Böhm Sweden 18 892 1.1× 151 0.6× 98 0.6× 131 1.7× 92 1.4× 31 1.0k
Minna Poukkula Finland 13 670 0.8× 383 1.6× 180 1.1× 192 2.5× 46 0.7× 14 1.1k
Matthew P. Swaffer United States 12 712 0.9× 256 1.1× 47 0.3× 113 1.4× 78 1.2× 19 929
Florence Janody Portugal 19 881 1.1× 567 2.4× 55 0.3× 100 1.3× 79 1.2× 31 1.2k
Frederic Sigoillot United States 18 1.5k 1.8× 395 1.7× 208 1.3× 322 4.1× 105 1.6× 27 1.6k

Countries citing papers authored by Mirko Theis

Since Specialization
Citations

This map shows the geographic impact of Mirko Theis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Theis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Theis more than expected).

Fields of papers citing papers by Mirko Theis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Theis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Theis. The network helps show where Mirko Theis may publish in the future.

Co-authorship network of co-authors of Mirko Theis

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Theis. A scholar is included among the top collaborators of Mirko Theis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Theis. Mirko Theis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klotz, Daniel Martin, Melanie Brux, Frank Buchholz, et al.. (2025). Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C. Cancer Gene Therapy. 32(3). 286–296. 2 indexed citations
2.
Klotz, Daniel Martin, Anna Dubrovska, Mirko Theis, et al.. (2023). Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer. Cancers. 15(15). 3774–3774. 6 indexed citations
3.
Ding, Li, Lukas Theo Schmitt, Melanie Brux, et al.. (2022). DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins. Life Science Alliance. 5(6). e202101321–e202101321. 5 indexed citations
4.
Bernhard, Sara V., Christian Kuffer, Dragomir B. Krastev, et al.. (2021). Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling. Cellular Oncology. 45(1). 103–119. 12 indexed citations
5.
Sreevalsan, Sandeep, Maciej Paszkowski‐Rogacz, Melanie Brux, et al.. (2020). MLLT 6 maintains PD ‐L1 expression and mediates tumor immune resistance. EMBO Reports. 21(12). e50155–e50155. 19 indexed citations
6.
Winzi, Maria, Núria Casas-Vila, Maciej Paszkowski‐Rogacz, et al.. (2018). The long noncoding RNA lncR492 inhibits neural differentiation of murine embryonic stem cells. PLoS ONE. 13(1). e0191682–e0191682. 15 indexed citations
7.
Toyoda, Yusuke, Cédric J. Cattin, Martin P. Stewart, et al.. (2017). Genome-scale single-cell mechanical phenotyping reveals disease-related genes involved in mitotic rounding. Nature Communications. 8(1). 1266–1266. 46 indexed citations
8.
Ding, Li, Maciej Paszkowski‐Rogacz, Maria Winzi, et al.. (2015). Systems Analyses Reveal Shared and Diverse Attributes of Oct4 Regulation in Pluripotent Cells. Cell Systems. 1(2). 141–151. 15 indexed citations
9.
Theis, Mirko, et al.. (2015). Targeting Human Long Noncoding Transcripts by Endoribonuclease-Prepared siRNAs. SLAS DISCOVERY. 20(8). 1018–1026. 11 indexed citations
10.
Raychaudhuri, Swasti, C. Loew, Roman Körner, et al.. (2014). Interplay of Acetyltransferase EP300 and the Proteasome System in Regulating Heat Shock Transcription Factor 1. Cell. 156(5). 975–985. 123 indexed citations
11.
Chakraborty, Debojyoti, Dennis Kappei, Mirko Theis, et al.. (2012). Combined RNAi and localization for functionally dissecting long noncoding RNAs. Nature Methods. 9(4). 360–362. 49 indexed citations
12.
Surendranath, Vineeth, Mirko Theis, Bianca Habermann, & Frank Buchholz. (2012). Designing Efficient and Specific Endoribonuclease-Prepared siRNAs. Methods in molecular biology. 942. 193–204. 15 indexed citations
13.
Leushacke, Marc, Ralf Spörle, Christof Bernemann, et al.. (2011). An RNA Interference Phenotypic Screen Identifies a Role for FGF Signals in Colon Cancer Progression. PLoS ONE. 6(8). e23381–e23381. 21 indexed citations
14.
Theis, Mirko & Frank Buchholz. (2010). MISSION esiRNA for RNAi Screening in Mammalian Cells. Journal of Visualized Experiments. 11 indexed citations
15.
Theis, Mirko & Frank Buchholz. (2010). High-throughput RNAi screening in mammalian cells with esiRNAs. Methods. 53(4). 424–429. 13 indexed citations
16.
Kittler, Ralf, Laurence Pelletier, Anne‐Kristin Heninger, et al.. (2007). Genome-scale RNAi profiling of cell division in human tissue culture cells. Nature Cell Biology. 9(12). 1401–1412. 233 indexed citations
17.
Theis, Mirko, et al.. (2006). Optimal Formulation of Complex Chemical Systems with a Genetic Algorithm. ARCA (Università Ca' Foscari Venezia). 13 indexed citations
18.
Buchholz, Frank, Ralf Kittler, Mikołaj Słabicki, & Mirko Theis. (2006). Enzymatically prepared RNAi libraries. Nature Methods. 3(9). 696–700. 52 indexed citations
19.
Kettenberger, Hubert, et al.. (2005). Structure of an RNA polymerase II–RNA inhibitor complex elucidates transcription regulation by noncoding RNAs. Nature Structural & Molecular Biology. 13(1). 44–48. 61 indexed citations
20.
Theis, Mirko, et al.. (1996). Uptake and intracellular transport pathways of fluorescent lipid analogues inAmoeba proteus (Rhizopoda: Amoebida). PROTOPLASMA. 193(1-4). 91–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026